. Overview We are a pioneering diagnostics technology company. Our mission is to expand access to novel molecular diagnostic testing, most immediately in the transplanted organ rejection testing category. We are developing molecular diagnostic test kits designed to empower our customers to run their own tests in-house to participate in the patient-care value chain, which is counter-positioned with the send-out-testing central laboratory model. Our decentralized approach also puts testing in the ...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001642380-26-000004 | EDGAR | 80K words |
| 2025-03-24 | 2024-12-31 | 0000950170-25-043852 | EDGAR | — |
| 2024-04-16 | 2023-12-31 | 0001493152-24-014720 | EDGAR | — |
| 2023-04-12 | 2022-12-31 | 0001493152-23-012005 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001493152-22-006677 | EDGAR | — |
| 2021-03-19 | 2020-12-31 | 0001493152-21-006465 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001493152-20-004738 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001493152-19-004549 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001140361-18-016477 | EDGAR | — |
| 2017-02-27 | 2016-12-31 | 0001140361-17-009369 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-274266 | EDGAR | 46K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106552 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069213 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125365 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001493152-24-030793 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019842 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040121 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027603 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-016796 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031415 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001493152-22-022151 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001493152-22-013051 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001493152-26-012915 | EDGAR | 8K words |
| 2026-02-26 | 0001493152-26-008169 | EDGAR | — |
| 2026-02-12 | 0001493152-26-006473 | EDGAR | — |
| 2026-02-11 | 0001493152-26-006117 | EDGAR | — |
| 2025-11-10 | 0001493152-25-021513 | EDGAR | — |
| 2025-10-02 | 0001493152-25-016685 | EDGAR | — |
| 2025-09-19 | 0001493152-25-014240 | EDGAR | — |
| 2025-08-11 | 0001641172-25-022974 | EDGAR | — |
| 2025-07-02 | 0001641172-25-017590 | EDGAR | — |
| 2025-06-17 | 0001641172-25-015338 | EDGAR | — |
271 total filings indexed. 239 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001642380 |
| Ticker | IMDX |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | CA |
| Website | https://www.imdxinc.com |
| Listed | 2015-12-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IMDX (~200 tokens, structured JSON with cryptographic provenance)